Come up with a name for your new list and we'll add to it:
StemoniX raised a round of funding on August 22, 2018. Investors include
Brightstone Venture Capital.
StemoniX provides products and services for drug discovery and development. It structures human iPSC-derived cells into physiologically relevant microtissues with accelerated cell maturity that mimic …